Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
Clinical trial NCT03510741 · COMPLETED
Trial details
- NCT number
- NCT03510741
- Sponsor
- Pakistan Institute of Living and Learning
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-12-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.